Nav: Home

Which strategies are most effective for reducing use of low-value health services?

July 13, 2016

The Institute of Medicine estimates that up to 30% of care provided in the United States is unnecessary and provides little value to patients given the cost and available alternatives. However, a new by researchers at The Dartmouth Institute for Health Policy and Clinical Practice finds that despite growing acceptance of the term "low-value care" by healthcare practitioners, strategies on how to reduce its use have not been studied consistently or compared to one another to determine effectiveness on a broad scale.

The Dartmouth Institute study, published this week in Medical Care Research and Review, is the first systematic literature review to examine the entire field of interventions designed to reduce low-value care. It also outlines which strategies are potentially the most effective in improving care delivery. Through an analysis of more than 100 articles published in academic journals prior to spring 2015, the study looked at 10 types of low-value care reduction approaches implemented at healthcare settings across the country. The researchers found that some of the more effective interventions included:

-- Implementing multicomponent strategies targeting both patient and clinician involvement. Examples include distributing educational infortmation to patients on treatment options, and giving physicans decision support tools to navigate guidelines and protocols on administering treatment.

-- Providing feedback to physicans and medical staff on their use of low-value care. Examples include offering suggestions for change, setting achievable benchmarks and providing tools for improvement.

Other interventions addressed in the literature review focused on patient cost sharing (the notion of shifting care costs to encourage consumers to explore options) as well as clinician education. The researchers also highlighted approaches that are gaining more interest in the field, such as, provider report cards, pay-for-performance systems, insurer restrictions and risk-sharing contracts between insurers and providers. However, the team found little research on the effectiveness of these strategies, concluding that measuring their success in reducing low-value care should be a priority for future research.

"Through categorizing services based on value, we have the potential to test approaches that can increase the overall value of care," says lead author Carrie Colla, PhD. "This is an important step in eliminating low-value care and building a base of knowledge about practice and health care delivery innovation."

To read the full study:

The Dartmouth Institute for Health Policy & Clinical Practice

Related Research Articles:

Related Research Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Climate Crisis
There's no greater threat to humanity than climate change. What can we do to stop the worst consequences? This hour, TED speakers explore how we can save our planet and whether we can do it in time. Guests include climate activist Greta Thunberg, chemical engineer Jennifer Wilcox, research scientist Sean Davis, food innovator Bruce Friedrich, and psychologist Per Espen Stoknes.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...